A simple and rapid method for the determination of recombinant retrovirus titer by G418 selection

Gene Therapy

Volumn 3, Issue 11, 1996, Pages 1018-1020

  Byun, J ^a   Kim, J M ^a   Kim, S H ^a   Yim, J ^a   Robbins, P D ^b   Kim, Sunyoung ^a  

^a Seoul National University   (South Korea)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Gene therapy; Quantification; Retrovirus; Virus titer

Indexed keywords

ANTIBIOTIC G 418; VIRUS VECTOR;

ARTICLE; CELL STRAIN 3T3; GENE THERAPY; GENETIC TRANSDUCTION; PRIORITY JOURNAL; RETROVIRUS; VIRUS RECOMBINANT;

3T3 CELLS; ANIMALS; ANTI-BACTERIAL AGENTS; CELL DIVISION; GENETIC VECTORS; GENTAMICINS; MICE; RECOMBINATION, GENETIC; RETROVIRIDAE;

UNIDENTIFIED RETROVIRUS;

EID: 0029957424     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marshall E. Gene therapy's growing pains. Special News Report. Science 1995; 269: 1050-1055.
2. Goff S, Traktman P, Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of vinon reverse transcriptase. J Virol 1981; 38: 239-248.
3. Huszar D, Ellis J, Bernstein A. A rapid and accurate method for determining the titer of retrovirus vectors lacking a selectable marker. Technique 1989; 1: 28-32.
4. Miyao Y et al. A simplified general method for determination of recombinant retrovirus titers. Cell Struct Funct 1995; 20-177-183.
5. Beck E et al. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 1982; 19: 327-336.
6. Morgenstern JP, Land H. Advanced mammalian gene transfer, high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell Line. Nucleic Acids Res 1990; 18: 3587-3596.
7. An G, Hidaka K, Siminovitch L. Expression of bacterial beta-galactosidase in animal cells. Mol Cell Biol 1982; 2: 1628-1632.
8. Jefferson RA, Kavanagh TA, Bevan MW. GUS fusions: beta-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J 1987; 6: 3901-3907.
9. Colbere-Garapin F, Horodniceanu F, Kourilsky P, Garapin AC. A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol 1981; 150: 1-14.
10. Southern PJ, Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under the control of the SV40 early region promoter. J Mol Appl Genet 1982; 1: 327-341.
11. Van Doren K, Hanahan D, Gluzman Y. Infection of eukaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol 1984; 50: 606-614.
12. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-2752.
13. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-990.
14. Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
15. Russell SJ. Making high titer retroviral producer cells. In: Collins MKL (ed). Practical Molecular Virology: Virol Vectors for Gene Expression. Humana Press: Clifton, NJ, 1991, pp 29-14.
16. Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete GM-CSF stimulates potent, specific and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
17. Ghattas IR, Sanes JR, Major JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991; 11: 5848-5859.